Mr Santosh Sahadu Bhujbal

Profile Image
Doctoral Candidate - Doctor of Philosophy


Santosh is a Doctoral Candidate at the University of Auckland Medical and Health Sciences, specializing in Ophthalmology. He completed his Bachelor of Pharmacy (BPharm) from the University of Pune with a First Class in 2012 and Master of Pharmacy degree in Pharmaceutics (MPharm, Pharmaceutics) from the same university (2014).

Santosh is a research professional with over seven years of industrial experience in formulation research and development of various pharmaceutical drug delivery systems and analysis. Expertise in QbD formulation and process optimization, technology transfer, scale-up, validation, GMP, and clinical manufacturing. He is having a good understanding of regulatory guidelines and preparation of documentation as per FDA requirements. Santosh has been working on Formulation Research and development of Injectables, Ophthalmic, and Inhalation formulations and has gained valuable experience working on developing various ophthalmic and injectable drug delivery systems. Before joining the University of Auckland, he worked with Cipla: The leading global pharmaceutical company in India, as a Deputy Manager in Formulation development R&D. Before that, he worked as part of the Sun Pharma group’s R&D team, an innovation-based Indian company that makes pharmaceutical products for various regulated and semi-regulated markets around the world. Santosh also served as a Formulation development scientist for Mylan Laboratories (the second-largest generic and specialty pharmaceuticals company in the world) and Micro Labs limited. Santosh is a passionate formulation scientist with responsible behavior, and he wants to leave his positive footprints at every place where he has invested his time.


Research | Current

His research interests include pre-formulation, formulation development, pharmacokinetic and pharmacodynamic evaluation of injectable and ophthalmic drug delivery systems. 

Our current research project will investigate a novel eye drop that tackles both tear film instability and inflammation to break the vicious circle of dry eye disease (DED). 

For further information on the current research interests, please visit the BOTU website.

Areas of expertise

Formulation development and drug delivery of Ophthalmic, Inhalation, and Injectable dosage forms.